However, AAV's limited cargo capacity prevents its application to therapies of inherited retinal diseases due to mutations of genes over 5 kb, like Stargardt's disease (STGD) and Usher syndrome type IB (USH1B). The gene discussed is MYO7A; the disease is severe early-childhood-onset retinal dystrophy.